Activist investing
Jim Cramer: Stop Speculating on Deals
I'm all in favor of mergers and acquisitions -- the more we get, the higher the stock market goes -- but I am not in favor of making conclusions based on tips about deals.
How I'd Play AT&T Now
I love when activist investors, in this case Elliott Management, get involved in a name that I am already long.
Fed Finally Gets It, Calling AT&T and Microsoft Delivers: Market Recon
A dividend hike and a big buyback authorization by Mr. Softee should produce value for shareholders.
Own AT&T? Verizon Has a Better Dividend, Better Focus
Elliott Management has expressed concern over not just the expense made in diversifying AT&T's overall business direction, but also in the reshuffling of leadership at the C-level.
Nordstrom Continues Run as Retail Optimism Accelerates
Nordstrom is turning the ship around from its 52 week lows. As retail foments its rift, is the company now a winner?
Do Activists Have an Answer at Bed Bath & Beyond?
Is a turnaround even possible anymore?
Bed Bath & Beyond Continues Its Slide After Dismal Quarterly Report
Will BBBY be the next retailer to bite the dust?
Wall Street Voices Skepticism on AbbVie's Aggressive Allergan Acquisition
Despite the financial positivity, many analysts warn the deal could have hiccups ahead.
Think AbbVie Is Overpaying for Allergan? Pfizer Offered Way More in 2015
PFE was ready to pay $160 billion until U.S. regulators blocked the deal.
Charts of the Day: The States of U.S. Gambling
A bit of context to simmer on following the big deal between Caesars and Eldorado.